A synthetic peptide for use as a blocking control in assays to test for specificity of ATXN2 antibody, Alternative Names: ATXN2 control peptide, ATXN2 antibody Blocking Peptide, Anti-ATXN2 Blocking Peptide, ataxin 2 Blocking Peptide, ATX2 Blocking Peptide, FLJ46772 Blocking Peptide, SCA2 Blocking Peptide, TNRC13 Blocking Peptide, ATXN2, ATXN-2, ATXN 2, ATXN-2 Blocking Peptide, ATXN 2 Blocking Peptide
ATXN2
Reactivité: Humain, Singe
Hôte: Synthetic
BP
Indications d'application
Optimal conditions should be determined by the investigator
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Conseil sur la manipulation
Avoid repeated freeze/thaw cycles.
Stock
-20 °C
Stockage commentaire
Store at -20 °C long term.
Antigène
Ataxin 2 (ATXN2)
Sujet
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA ty.